Please join @kireports in welcoming @mchanmd.bsky.social &
@drpriyajohn.bsky.social, our newest in KI Reports SoMe leadership, for continued outstanding #FOAMed.
@drpriyajohn.bsky.social, our newest in KI Reports SoMe leadership, for continued outstanding #FOAMed.
January 24, 2025 at 2:49 AM
Please join @kireports in welcoming @mchanmd.bsky.social &
@drpriyajohn.bsky.social, our newest in KI Reports SoMe leadership, for continued outstanding #FOAMed.
@drpriyajohn.bsky.social, our newest in KI Reports SoMe leadership, for continued outstanding #FOAMed.
Announcing the #NephJC #kireports internship collaboration, @nephjc.bsky.social and @kireports.bsky.social joining forces
www.nephjc.com/intern-app for details and to apply!
#NephSky
www.nephjc.com/intern-app for details and to apply!
#NephSky
NephJC Editorial Internship — NephJC
www.nephjc.com
March 8, 2025 at 6:06 AM
Announcing the #NephJC #kireports internship collaboration, @nephjc.bsky.social and @kireports.bsky.social joining forces
www.nephjc.com/intern-app for details and to apply!
#NephSky
www.nephjc.com/intern-app for details and to apply!
#NephSky
Adults with #IgAN are at greater risk of adverse kidney outcomes versus nonglomerular CKD and substantially higher risks of heart failure and death compared with no CKD ca. 2026 from @KIReports
#Nephpearls #RKDSummit #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/42027552/
#Nephpearls #RKDSummit #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/42027552/
September 26, 2026 at 6:54 PM
Adults with #IgAN are at greater risk of adverse kidney outcomes versus nonglomerular CKD and substantially higher risks of heart failure and death compared with no CKD ca. 2026 from @KIReports
#Nephpearls #RKDSummit #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/42027552/
#Nephpearls #RKDSummit #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/42027552/
🔬 Bring your research to #ISNWCN! Present to the global kidney community, build collaborations, be considered for WCN Abstract Awards & have your accepted abstract published in the @KIReports congress supplement.
📅 Submit by Oct 28: https://bit.ly/4uQjWqE
📅 Submit by Oct 28: https://bit.ly/4uQjWqE
October 1, 2026 at 6:00 AM
🔬 Bring your research to #ISNWCN! Present to the global kidney community, build collaborations, be considered for WCN Abstract Awards & have your accepted abstract published in the @KIReports congress supplement.
📅 Submit by Oct 28: https://bit.ly/4uQjWqE
📅 Submit by Oct 28: https://bit.ly/4uQjWqE
Hi #Xtwitter #NephTwitter #SkyTwitter
Many in the #Nephrology community are migrating to #BlueSky
Looks enticing, big names are on their way, @kireports will expand our footprint too!
Here is a little starter-pack to get started, thanks #NephJC
twitter.com/NephJC/s...
Many in the #Nephrology community are migrating to #BlueSky
Looks enticing, big names are on their way, @kireports will expand our footprint too!
Here is a little starter-pack to get started, thanks #NephJC
twitter.com/NephJC/s...
November 12, 2024 at 11:12 PM
Hi #Xtwitter #NephTwitter #SkyTwitter
Many in the #Nephrology community are migrating to #BlueSky
Looks enticing, big names are on their way, @kireports will expand our footprint too!
Here is a little starter-pack to get started, thanks #NephJC
twitter.com/NephJC/s...
Many in the #Nephrology community are migrating to #BlueSky
Looks enticing, big names are on their way, @kireports will expand our footprint too!
Here is a little starter-pack to get started, thanks #NephJC
twitter.com/NephJC/s...
1/ 🚨Tweetorial Alert🚨
Hey #NephSky! Welcome to a 🆕 #skeetorial brought to you by @KIReports @ISNkidneycare. Please also check out www.kireportscommunity.org educational #blogposts. FOLLOW US!
Hey #NephSky! Welcome to a 🆕 #skeetorial brought to you by @KIReports @ISNkidneycare. Please also check out www.kireportscommunity.org educational #blogposts. FOLLOW US!
September 9, 2026 at 5:23 AM
1/ 🚨Tweetorial Alert🚨
Hey #NephSky! Welcome to a 🆕 #skeetorial brought to you by @KIReports @ISNkidneycare. Please also check out www.kireportscommunity.org educational #blogposts. FOLLOW US!
Hey #NephSky! Welcome to a 🆕 #skeetorial brought to you by @KIReports @ISNkidneycare. Please also check out www.kireportscommunity.org educational #blogposts. FOLLOW US!
September 2, 2026 at 11:05 AM
2A/ 🚨Our topic from @KIReports: Early determination of Tacrolimus Concentration-Dose ratio identifies risk of allograft loss in kidney transplantation
There are no conflicts of interest. #Medsky #nephsky @theisn.org
www.kireports.org/article/S246...
There are no conflicts of interest. #Medsky #nephsky @theisn.org
www.kireports.org/article/S246...
June 20, 2025 at 6:46 AM
2A/ 🚨Our topic from @KIReports: Early determination of Tacrolimus Concentration-Dose ratio identifies risk of allograft loss in kidney transplantation
There are no conflicts of interest. #Medsky #nephsky @theisn.org
www.kireports.org/article/S246...
There are no conflicts of interest. #Medsky #nephsky @theisn.org
www.kireports.org/article/S246...
1/
Hey #NephSky!
Welcome to a 🆕 #skeetorial brought to you by @KIReports.
Want more, check out the blog here:
www.kireportscommunity.org/post/type-1-...
Hey #NephSky!
Welcome to a 🆕 #skeetorial brought to you by @KIReports.
Want more, check out the blog here:
www.kireportscommunity.org/post/type-1-...
Type 1 Diabetes: Two Roads Diverged, How Far Have We Come?
Author: Brian Rifkin, MDHattiesburg ClinicHattiesburg, MSCare of patients with diabetes has advanced significantly since Banting and Best discovered insulin over a century ago. The prognosis of type 1...
www.kireportscommunity.org
November 23, 2024 at 7:52 PM
1/
Hey #NephSky!
Welcome to a 🆕 #skeetorial brought to you by @KIReports.
Want more, check out the blog here:
www.kireportscommunity.org/post/type-1-...
Hey #NephSky!
Welcome to a 🆕 #skeetorial brought to you by @KIReports.
Want more, check out the blog here:
www.kireportscommunity.org/post/type-1-...
Hey #NephSky‼️
A new @KIReports community blog on the use of #Flozins in #ADPKD
…and on #Bluesky #NephJC at 9pm 3/25/25, we will discuss the first ever KDIGO ADPKD 2025 guidelines.
A 1-2 punch 🥊 🥊 getting you up to date on ADPKD
www.kireportscommunity.org/post/polycys...
A new @KIReports community blog on the use of #Flozins in #ADPKD
…and on #Bluesky #NephJC at 9pm 3/25/25, we will discuss the first ever KDIGO ADPKD 2025 guidelines.
A 1-2 punch 🥊 🥊 getting you up to date on ADPKD
www.kireportscommunity.org/post/polycys...
Polycystic Kidney Disease: Ebb and Flozins
IntroductionAutosomal dominant polycystic kidney disease (ADPKD) is estimated to affect up to 12 million individuals and is the 4th most common cause of renal replacement therapy worldwide. The diagno...
www.kireportscommunity.org
March 23, 2025 at 1:37 AM
Hey #NephSky‼️
A new @KIReports community blog on the use of #Flozins in #ADPKD
…and on #Bluesky #NephJC at 9pm 3/25/25, we will discuss the first ever KDIGO ADPKD 2025 guidelines.
A 1-2 punch 🥊 🥊 getting you up to date on ADPKD
www.kireportscommunity.org/post/polycys...
A new @KIReports community blog on the use of #Flozins in #ADPKD
…and on #Bluesky #NephJC at 9pm 3/25/25, we will discuss the first ever KDIGO ADPKD 2025 guidelines.
A 1-2 punch 🥊 🥊 getting you up to date on ADPKD
www.kireportscommunity.org/post/polycys...
Excited to share our review in #KIReports – a real milestone for me!
#CKD at the Crossroads: From Failure to Future Therapies
1️⃣ Current & emerging CKD therapies
2️⃣ Why proven treatments are still underused
3️⃣ Practical checklist to help clinicians implement kidney protective therapies in practice
#CKD at the Crossroads: From Failure to Future Therapies
1️⃣ Current & emerging CKD therapies
2️⃣ Why proven treatments are still underused
3️⃣ Practical checklist to help clinicians implement kidney protective therapies in practice
#CKDs at the Crossroads: From Failures to #Future #Therapies
https://doi.org/10.1016/j.ekir.2025.09.050
#KIRReview
https://doi.org/10.1016/j.ekir.2025.09.050
#KIRReview
January 25, 2026 at 3:34 AM
Excited to share our review in #KIReports – a real milestone for me!
#CKD at the Crossroads: From Failure to Future Therapies
1️⃣ Current & emerging CKD therapies
2️⃣ Why proven treatments are still underused
3️⃣ Practical checklist to help clinicians implement kidney protective therapies in practice
#CKD at the Crossroads: From Failure to Future Therapies
1️⃣ Current & emerging CKD therapies
2️⃣ Why proven treatments are still underused
3️⃣ Practical checklist to help clinicians implement kidney protective therapies in practice
💥Hey #NephSky! Welcome to a 🆕 #tweetorial #xtorial brought to you by @KIReports @ISNkidneycare #Skytorial. Our author is @elbaonelida.bsky.social nephrologist at Hospital General de Mexico @hgm_nefrologia. Please also check out www.kireportscommunity.org educational #blogposts. FOLLOW US!🫰
April 19, 2025 at 1:20 AM
💥Hey #NephSky! Welcome to a 🆕 #tweetorial #xtorial brought to you by @KIReports @ISNkidneycare #Skytorial. Our author is @elbaonelida.bsky.social nephrologist at Hospital General de Mexico @hgm_nefrologia. Please also check out www.kireportscommunity.org educational #blogposts. FOLLOW US!🫰
📢Does Lanthanum Carbonate provide a new efficient treatment for primary hyperoxaluria?
👀Let's look at the evidence
✅ Check out the VA from @KIReports
@ISNeducation.bluesky.social
👀Let's look at the evidence
✅ Check out the VA from @KIReports
@ISNeducation.bluesky.social
A Targeted Release Capsule of #Lanthanum #Carbonate: a New Efficient Cheap Treatment for Primary #Hyperoxalurias
#VIsualAbstract by @KajareeG
www.kireports.org/ar...
#VIsualAbstract by @KajareeG
www.kireports.org/ar...
January 3, 2025 at 1:54 PM
📢Does Lanthanum Carbonate provide a new efficient treatment for primary hyperoxaluria?
👀Let's look at the evidence
✅ Check out the VA from @KIReports
@ISNeducation.bluesky.social
👀Let's look at the evidence
✅ Check out the VA from @KIReports
@ISNeducation.bluesky.social
🧵 #KIreports thread by Cristina Popa @nephroseeker.medsky.social (Romanian nephrologist)
🙏Thank you @mchanmd.bsky.social @brianrifkin.bsky.social and @sophia-kidney.bsky.social for the feedback
🙏Thank you @mchanmd.bsky.social @brianrifkin.bsky.social and @sophia-kidney.bsky.social for the feedback
Alice In Wonderland Says Thank You
ALT: Alice In Wonderland Says Thank You
static.klipy.com
May 20, 2026 at 9:10 PM
🧵 #KIreports thread by Cristina Popa @nephroseeker.medsky.social (Romanian nephrologist)
🙏Thank you @mchanmd.bsky.social @brianrifkin.bsky.social and @sophia-kidney.bsky.social for the feedback
🙏Thank you @mchanmd.bsky.social @brianrifkin.bsky.social and @sophia-kidney.bsky.social for the feedback
🧵 #KIreports thread by Cristina Popa @nephroseeker.medsky.social (Romanian nephrologist)
🙏Thank you, @mchanmd.bsky.social and @sophia-kidney.bsky.social for the feedback
🙏Thank you, @mchanmd.bsky.social and @sophia-kidney.bsky.social for the feedback
September 17, 2026 at 4:06 PM
🧵 #KIreports thread by Cristina Popa @nephroseeker.medsky.social (Romanian nephrologist)
🙏Thank you, @mchanmd.bsky.social and @sophia-kidney.bsky.social for the feedback
🙏Thank you, @mchanmd.bsky.social and @sophia-kidney.bsky.social for the feedback
Our longitudinal study of #SARS-CoV-2 immunity in dialysis patients during early #omicron era now up on #KIReports. I was surprised by the heterogeneous responses and low concordance of Ab and T cell immunity. doi.org/10.1016/j.ek...
Redirecting
doi.org
November 21, 2024 at 12:52 PM
Our longitudinal study of #SARS-CoV-2 immunity in dialysis patients during early #omicron era now up on #KIReports. I was surprised by the heterogeneous responses and low concordance of Ab and T cell immunity. doi.org/10.1016/j.ek...
📢Happy to share our blog @KIReports
💥"Does Early Start PD Improve Patient Outcomes?"
Thank you 🌟 @sophia-kidney.bsky.social @mchanmd.bsky.social @ghobby.bsky.social @isnkidneycare.bsky.social
👇
www.kireportscommunity.org/post/the-clo...
💥"Does Early Start PD Improve Patient Outcomes?"
Thank you 🌟 @sophia-kidney.bsky.social @mchanmd.bsky.social @ghobby.bsky.social @isnkidneycare.bsky.social
👇
www.kireportscommunity.org/post/the-clo...
The Clock Starts Now: Does Early Start PD Improve Patient Outcomes?
This study compares Early Start Peritoneal Dialysis (ESPD) with Conventional Start Peritoneal Dialysis (CSPD), finding that while ESPD may l
www.kireportscommunity.org
November 14, 2024 at 12:31 PM
📢Happy to share our blog @KIReports
💥"Does Early Start PD Improve Patient Outcomes?"
Thank you 🌟 @sophia-kidney.bsky.social @mchanmd.bsky.social @ghobby.bsky.social @isnkidneycare.bsky.social
👇
www.kireportscommunity.org/post/the-clo...
💥"Does Early Start PD Improve Patient Outcomes?"
Thank you 🌟 @sophia-kidney.bsky.social @mchanmd.bsky.social @ghobby.bsky.social @isnkidneycare.bsky.social
👇
www.kireportscommunity.org/post/the-clo...
Another @KIReports community blog. This time from me! This one is rather personal, as a physician with T1D (30 years in May 2025), I’ve fell a bit left out of all of the advances in diabetic nephropathy. Read more #NephSky #MedSky
www.kireportscommunity.org/post/type-1-...
www.kireportscommunity.org/post/type-1-...
Type 1 Diabetes: Two Roads Diverged, How Far Have We Come?
Author: Brian Rifkin, MDHattiesburg ClinicHattiesburg, MSCare of patients with diabetes has advanced significantly since Banting and Best discovered insulin over a century ago. The prognosis of type 1...
www.kireportscommunity.org
November 23, 2024 at 12:46 PM
Another @KIReports community blog. This time from me! This one is rather personal, as a physician with T1D (30 years in May 2025), I’ve fell a bit left out of all of the advances in diabetic nephropathy. Read more #NephSky #MedSky
www.kireportscommunity.org/post/type-1-...
www.kireportscommunity.org/post/type-1-...
1/ Hey #NephSky #MedSky 👋👋
Could a very high eGFR be a warning sign, not reassurance? This #KIreports editorial reframes "supra-normal" filtration as early cardiorenal stress and makes the case for a next-generation heat map
www.kireports.org/article/S246...
Could a very high eGFR be a warning sign, not reassurance? This #KIreports editorial reframes "supra-normal" filtration as early cardiorenal stress and makes the case for a next-generation heat map
www.kireports.org/article/S246...
May 20, 2026 at 9:10 PM
1/ Hey #NephSky #MedSky 👋👋
Could a very high eGFR be a warning sign, not reassurance? This #KIreports editorial reframes "supra-normal" filtration as early cardiorenal stress and makes the case for a next-generation heat map
www.kireports.org/article/S246...
Could a very high eGFR be a warning sign, not reassurance? This #KIreports editorial reframes "supra-normal" filtration as early cardiorenal stress and makes the case for a next-generation heat map
www.kireports.org/article/S246...
T0d: #NephJC
A recent #kireports electronic cohort-based study showed that compared with other primary GNs, in LN there is a slightly ⬇️risk of KRT. With LN-CKD 👉 higher risk of
🔸MACE HR 1.63 (95% CI, 1.32–2.02)
🔸all-cause mortality 1.65 (1.31–2.08)
www.kireports.org/ar...
A recent #kireports electronic cohort-based study showed that compared with other primary GNs, in LN there is a slightly ⬇️risk of KRT. With LN-CKD 👉 higher risk of
🔸MACE HR 1.63 (95% CI, 1.32–2.02)
🔸all-cause mortality 1.65 (1.31–2.08)
www.kireports.org/ar...
March 12, 2025 at 1:10 AM
T0d: #NephJC
A recent #kireports electronic cohort-based study showed that compared with other primary GNs, in LN there is a slightly ⬇️risk of KRT. With LN-CKD 👉 higher risk of
🔸MACE HR 1.63 (95% CI, 1.32–2.02)
🔸all-cause mortality 1.65 (1.31–2.08)
www.kireports.org/ar...
A recent #kireports electronic cohort-based study showed that compared with other primary GNs, in LN there is a slightly ⬇️risk of KRT. With LN-CKD 👉 higher risk of
🔸MACE HR 1.63 (95% CI, 1.32–2.02)
🔸all-cause mortality 1.65 (1.31–2.08)
www.kireports.org/ar...
💥Check out our recent publication in @KIReports
📌Dialysis During Pregnancy: Are We Any Closer to Clarity?
🤰💉 Optimal timing?
🧪 urea/creatinine signal
📊 what's reliable? biochemical markers or gestational renal shifts
📅 ideal prescription
www.kireports.org/article/S246...
📌Dialysis During Pregnancy: Are We Any Closer to Clarity?
🤰💉 Optimal timing?
🧪 urea/creatinine signal
📊 what's reliable? biochemical markers or gestational renal shifts
📅 ideal prescription
www.kireports.org/article/S246...
May 18, 2025 at 1:55 AM
💥Check out our recent publication in @KIReports
📌Dialysis During Pregnancy: Are We Any Closer to Clarity?
🤰💉 Optimal timing?
🧪 urea/creatinine signal
📊 what's reliable? biochemical markers or gestational renal shifts
📅 ideal prescription
www.kireports.org/article/S246...
📌Dialysis During Pregnancy: Are We Any Closer to Clarity?
🤰💉 Optimal timing?
🧪 urea/creatinine signal
📊 what's reliable? biochemical markers or gestational renal shifts
📅 ideal prescription
www.kireports.org/article/S246...
1/20 Hello everyone, welcome to www.kireportscommunity.org #Nephsky #Medsky Welcome to a #skytorial brought to you by @KIReports
Kidney Education | KI Reports Community
KI Reports Community is the blog page affiliated with KI Reports and the ISN, representing a less restricted space where a variety of content is presented, including expert commentaries, article summa...
www.kireportscommunity.org
April 16, 2026 at 4:19 AM
1/20 Hello everyone, welcome to www.kireportscommunity.org #Nephsky #Medsky Welcome to a #skytorial brought to you by @KIReports
23/ This has been another @KIReports skeetorial by @brianrifkin.bsky.social . Please share this #skeetorial with your followers and friends! Thanks to @sophia-kidney.bsky.social and @mchanmd.bsky.social for great feedback! Welcome to the good place, #NephSky
November 23, 2024 at 7:52 PM
23/ This has been another @KIReports skeetorial by @brianrifkin.bsky.social . Please share this #skeetorial with your followers and friends! Thanks to @sophia-kidney.bsky.social and @mchanmd.bsky.social for great feedback! Welcome to the good place, #NephSky
📣 Only two weeks left to submit your WCN’26 abstract! Don’t miss the chance to:
🌍 gain recognition at the 2026 global kidney care event
🏆 win one of 3 prestigious awards
📰 get your work published in KIReports® congress supplement
Submit by October 22➡️http://lite.spr.ly/6...
🌍 gain recognition at the 2026 global kidney care event
🏆 win one of 3 prestigious awards
📰 get your work published in KIReports® congress supplement
Submit by October 22➡️http://lite.spr.ly/6...
October 7, 2025 at 12:15 PM
📣 Only two weeks left to submit your WCN’26 abstract! Don’t miss the chance to:
🌍 gain recognition at the 2026 global kidney care event
🏆 win one of 3 prestigious awards
📰 get your work published in KIReports® congress supplement
Submit by October 22➡️http://lite.spr.ly/6...
🌍 gain recognition at the 2026 global kidney care event
🏆 win one of 3 prestigious awards
📰 get your work published in KIReports® congress supplement
Submit by October 22➡️http://lite.spr.ly/6...
🚨 New in @KIReports:
Not all IgA nephropathy is the same post-transplant! We explore key differences between recurrent and de novo IgAN and their clinical implications.
🧠 Read: www.kireports.org/article/S246...
Not all IgA nephropathy is the same post-transplant! We explore key differences between recurrent and de novo IgAN and their clinical implications.
🧠 Read: www.kireports.org/article/S246...
June 16, 2025 at 7:23 PM
🚨 New in @KIReports:
Not all IgA nephropathy is the same post-transplant! We explore key differences between recurrent and de novo IgAN and their clinical implications.
🧠 Read: www.kireports.org/article/S246...
Not all IgA nephropathy is the same post-transplant! We explore key differences between recurrent and de novo IgAN and their clinical implications.
🧠 Read: www.kireports.org/article/S246...